Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for the treatment of chronic inflammatory lymphedema, a double blind, placebo controlled, multicentric study.
Mitra A, Bhuyan G, Muralikrishna C, Naser SM, Ratha KK, Babu G, Venkateswarlu B, Dhoke S, Bagchi C, Singh R, Tripathi A, Rana R, Sharma BS, Khanduri S, Gupta B, Rao B, Kumar A, Padhi MM, Srikanth N, Dhiman KS, Tripathi KS. Mitra A, et al. Among authors: sharma bs. J Vector Borne Dis. 2024 Dec 5. doi: 10.4103/JVBD.JVBD_61_24. Online ahead of print. J Vector Borne Dis. 2024. PMID: 39636260 Free article.
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study.
Gundeti MS, Bhurke LW, Mundada PS, Murudkar S, Surve A, Sharma R, Mata S, Rana R, Singhal R, Vyas N, Khanduri S, Sharma BS, Srikanth N, Dhiman KS. Gundeti MS, et al. Among authors: sharma r, sharma bs. J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100325. doi: 10.1016/j.jaim.2020.05.010. Epub 2020 May 14. J Ayurveda Integr Med. 2022. PMID: 33446377 Free PMC article.
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis.
Srikanth N, Kumar A, Chandrasekhararao B, Singhal R, Yadav B, Khanduri S, Jameela S, Rai AK, Tripathi A, Rana R, Ahmad A, Sharma BS, Jaiswal A, Kotecha R; State Level Collaborators. Srikanth N, et al. Among authors: sharma bs. Front Public Health. 2022 Jul 6;10:904279. doi: 10.3389/fpubh.2022.904279. eCollection 2022. Front Public Health. 2022. PMID: 35900336 Free PMC article.
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial.
Singh H, Yadav B, Rai AK, Srivastava S, Saiprasad A, Jameela S, Singhal R, Muralidharan S, Mohan R, Chaudhary S, Rana R, Khanduri S, Sharma BS, Chandrasekhararao B, Srikanth N, Dhiman KS. Singh H, et al. Among authors: sharma bs. Complement Ther Med. 2023 Sep;76:102966. doi: 10.1016/j.ctim.2023.102966. Epub 2023 Jul 22. Complement Ther Med. 2023. PMID: 37482107 Free article. Clinical Trial.
Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'.
Gundeti MS, Bhurke LW, Mundada PS, Murudkar S, Surve A, Sharma R, Mata S, Rana R, Singhal R, Vyas N, Khanduri S, Sharma BS, Srikanth N, Dhiman KS. Gundeti MS, et al. Among authors: sharma r, sharma bs. J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100487. doi: 10.1016/j.jaim.2021.07.003. Epub 2021 Dec 27. J Ayurveda Integr Med. 2022. PMID: 34969588 Free PMC article. No abstract available.
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India.
Singh H, Srivastava S, Yadav B, Rai AK, Jameela S, Muralidharan S, Mohan R, Chaudhary S, Singhal R, Rana R, Khanduri S, Sharma BS, Chandrasekhararao B, Srikanth N, Chaturvedi S. Singh H, et al. Among authors: sharma bs. Complement Ther Med. 2022 Jun;66:102814. doi: 10.1016/j.ctim.2022.102814. Epub 2022 Feb 8. Complement Ther Med. 2022. PMID: 35149205 Free PMC article. Clinical Trial.
The Structural and Thermal properties of Badarashma Pishti.
Jagtap CY, Charde V, Rawat H, Dane G, Mishra AK, Narasimhaji CV, Sharma BS, Khanduri S, Singh R, Srikanth N, Acharya R. Jagtap CY, et al. Among authors: sharma bs. J Ayurveda Integr Med. 2024 Nov-Dec;15(6):100989. doi: 10.1016/j.jaim.2024.100989. Epub 2024 Nov 29. J Ayurveda Integr Med. 2024. PMID: 39615446 Free PMC article.
Establishment of the mechanism of purification and levigation of green chemistry-assisted biocomposites of red ochre (Gairika): synthesis, characterization, and antibacterial, prebiotic, antioxidant, and antacid activities of the traditional Ayurvedic medicine Laghu Sutashekhara Rasa.
Charde V, Kumar V, Dane G, Gandhi Y, Soni H, Jagtap C, Mishra SK, Shakya SK, Singh A, Singh R, Sharma BS, Khanduri S, Srikanth N, Acharya R, Webster TJ. Charde V, et al. Among authors: sharma bs. Front Chem. 2023 Nov 23;11:1271157. doi: 10.3389/fchem.2023.1271157. eCollection 2023. Front Chem. 2023. PMID: 38075496 Free PMC article.
Disparities in casemix, acute interventions, discharge destinations and mortality of patients with traumatic brain injury between Europe and India.
Gupta D, Singh RD, Vreeburg RJ, van Dijck JT, den Boogert HF, Sharma K, Praneeth K, Clarke DB, Lecky FE, Maas AI, Sinha VD, de Ruiter GC, Peul WC, van Essen TA; CENTER-TBI; CINTER-TBI. Gupta D, et al. J Glob Health. 2024 Nov 11;14:04227. doi: 10.7189/jogh.14.04227. J Glob Health. 2024. PMID: 39526450 Free PMC article.
471 results